Primal Therapies

About:

Primal Therapies is a biotechnology company that specializes in the fields of biofilm management and healthcare.

Description:

Primal Therapies is a biotechnology company that specializes in the fields of biofilm management and healthcare. The company developed a pipeline of proprietary formulas containing active ingredients that target the metabolism of harmful bacteria. Primal Therapies was founded in 2012 and headquartered in Idaho, United States.

Total Funding Amount:

$677000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boise, Idaho, United States

Founded Date:

2012-01-01

Founders:

Emily Stein, William Robinson

Number of Employees:

1-10

Last Funding Date:

2016-10-24

IPO Status:

Private

Industries: